The Hindu Editorial Analysis : 1st October 2026

The Hindu Editorial Analysis

We understand the significance of reading The Hindu newspaper for enhancing reading skills, improving comprehension of passages, staying informed about current events, enhancing essay writing, and more, especially for banking aspirants who need to focus on editorials for vocabulary building. This article will explore today’s editorial points, along with practice questions and key vocabulary.

SC Raises Questions to Centre Over High Mark-Ups on Essential Medicines

• The Supreme Court on Tuesday raised serious concerns about the huge difference between the price at which essential medicines are sold to retailers and the price at which they are sold to patients. The court said that such high mark-ups put a heavy burden on taxpayers and described the situation as “carnage”.
• A Bench of Justice Vikram Nath and Justice Sandeep Mehta asked the Central Government why the 16% retailer margin fixed under the Drugs (Prices Control) Order (DPCO), 2013 should not be applied to all essential medicines. The court said this could help stop excessive increases over the Price to Retailer (PTR).
• The Bench said, “Why not keep the 16% margin on MRP, which is prescribed in the DPCO, on everything? … Ultimately, the loser is the taxpayer. This is carnage, as simple as that.”
• These remarks were made while the Supreme Court was hearing petitions filed by advocate Kishan Chand Jain and paediatric surgeon Sanjay Kulshrestha. They have asked the court to intervene and regulate the prices of medicines, medical equipment and generic drugs so that they become more affordable for people.
• Justice Sandeep Mehta especially referred to an essential cancer medicine that was supplied to retailers for around ₹3,000 but was sold to patients for nearly ₹27,000. He questioned who was benefiting from the difference of about ₹24,000 between the retailer price and the final selling price.
• Referring to this large gap in price, Justice Mehta said, “You tell us why this difference… Where does this chunk of money go? Ten times…”
• Justice Mehta also mentioned Rosuvas, a commonly used statin medicine, and pointed out that one strip of the medicine costs around ₹240.
• He said that Rosuvas falls under the non-scheduled category, but when it is combined with aspirin, it becomes a scheduled formulation and comes under price control rules of the DPCO.
• According to the court, the Rosuvas and aspirin combination costs around ₹70 per strip, even though a combination medicine would normally be expected to cost more than a medicine containing only one drug.
• Pointing to this difference, Justice Mehta said, “So a combination should be more costly. It should be costlier, but the disparity is there.”
• Solicitor-General Tushar Mehta, appearing for the Central Government, accepted that the issue raised by the court was important and said that the government would have to find a solution while “balancing equities”.
• However, the Solicitor-General argued that pharmaceutical companies were not the main beneficiaries of these high mark-ups. According to him, private hospitals were the ones gaining the most from them.
• The law officer told the court, “The pharma company is not the gainer. The gainer is the private hospital.”
• The Bench also expressed concern over the practice followed by many private hospitals of asking patients to buy medicines only from the hospitals’ own pharmacies.
• The court said that such a practice leaves patients with very little choice and stops them from purchasing the same medicines at cheaper rates from outside medical stores.
• The Bench also highlighted the effect of high medicine prices on government finances. It observed that when treatment costs are covered under government-funded schemes such as Ayushman Bharat, the burden of paying those costs ultimately falls on taxpayers.
• Solicitor-General Tushar Mehta asked the court for some time to place on record details of the existing system that regulates drug pricing in the country.
• He assured the Bench that he would present the government’s detailed submissions during the next hearing.
• After considering the request, the Bench fixed October 12 as the next date for hearing the matter.
• Through their petitions, the petitioners have asked for directions to make drug formulations more affordable by controlling the alleged overpricing of essential medicines by pharmaceutical companies and retailers.
• They have also sought stricter implementation of the price-control provisions under the Drugs (Prices Control) Order, 2013 so that violations of the prescribed pricing system can be prevented.
• The petitioners have further asked for steps to stop disproportionate profit margins at different levels of the medicine supply chain.
• Earlier, the Supreme Court had described the huge difference between the Price to Retailer (PTR) and the Maximum Retail Price (MRP) of medicines as “dacoity”.
• At that time, the court had also drawn attention to the financial difficulties faced by patients who struggle to pay for expensive medical treatment.

Indian Delegation Participates in SCO Meeting Held in Pakistan

• Pakistan announced that it will host the Shanghai Cooperation Organisation (SCO) Summit in August 2027.
• An Indian delegation, led by a senior official from the Ministry of External Affairs, attended a preparatory meeting in Islamabad.
• This was the first official visit by an Indian delegation to Pakistan since Operation Sindoor took place last year.
• The three-day meeting of SCO National Coordinators started on Monday in Islamabad.
• The meeting was held just a few days after India and Pakistan exchanged strong views on terrorism and the Kashmir issue at the United Nations General Assembly (UNGA).
• During their speeches at the UNGA, External Affairs Minister S. Jaishankar and Pakistan Prime Minister Shehbaz Sharif made allegations against each other’s countries.
• Indian and Pakistani diplomats also used their right of reply at the UNGA to answer the statements made by the other side on the international stage last week.
• On Tuesday, India rejected the comments made by Turkish President Recep Tayyip Erdogan about Kashmir in his UNGA speech.
• India was represented at the SCO National Coordinators’ meeting by Alok Dimri, Joint Secretary (Multilaterals and Economic Relations).
• His presence showed a higher level of Indian participation than in several SCO meetings held under Pakistan’s chairmanship this year.
• In mid-September, a meeting of the SCO Regional Anti-Terror Structure was held in Islamabad.
• India was represented at that meeting by its Charge d’Affaires in Pakistan, Satyapal Pandey.
• However, India did not send a separate delegation for that meeting.
• In a statement, Pakistan’s Ministry of Foreign Affairs said that Pakistan’s SCO Chairship for 2026–2027 would work on the theme, “Turning Vision into Action: Connectivity, Innovation and Shared Prosperity.”
• Indian officials said that the SCO coordinators’ meeting was being held in a multilateral format involving many countries.
• They made it clear that the meeting should not be seen as having any special importance for India-Pakistan bilateral relations.
• However, India’s participation keeps the door open for higher-level participation in future SCO meetings, including Ministerial-level events and the Heads of Council meeting.
• Prime Minister Narendra Modi has been invited to attend the Heads of Council meeting.
• So far, New Delhi has stayed away from leaders’ meetings held in both Delhi and Islamabad.
• In 2023, Prime Minister Narendra Modi hosted the SCO Heads of Council Summit through a virtual meeting.
• In the same year, External Affairs Minister S. Jaishankar hosted Pakistan Foreign Minister Bilawal Bhutto in person during the SCO Foreign Ministers’ meeting held in Goa.
• In 2024, Mr. Jaishankar travelled to Islamabad to attend the SCO Heads of Government meeting.
• The Ministry of External Affairs has not yet said whether Prime Minister Modi will travel to Pakistan next year.
• At the same time, the Ministry has also not ruled out the possibility of such a visit.
• During a media briefing on Tuesday, Ministry spokesperson Randhir Jaiswal brushed aside a question about whether India would oppose Türkiye becoming a member of the SCO.
• Earlier this month, Turkish President Recep Tayyip Erdogan told journalists that Türkiye wanted a higher level of involvement in the SCO than its present observer status.
• His statement suggested that Türkiye could apply for full SCO membership next year.
• This possibility is being discussed especially because of Türkiye’s close relationship and military cooperation with Pakistan, which will host the SCO Summit.
• Responding to the issue, Mr. Jaiswal said that any decision on membership would be taken together by all SCO member countries.
• He said that whenever the issue of membership comes up, all SCO members will collectively decide how to move forward on it.
• Jaiswal also criticised President Erdogan for mentioning Kashmir in his speech at the United Nations General Assembly last week.

OpenAI Introduces GPT-6.1 Sol and ‘Dots’ AI Agents at DevDay

• OpenAI CEO Sam Altman on Tuesday introduced GPT-6.1 Sol at the company’s DevDay event held in San Francisco.
• He described GPT-6.1 Sol as a lower-cost AI model that offers intelligence very close to GPT-6 Astra while costing only one-fifth as much for coding and building work.
• Sam Altman said the model has been created to provide a good balance between performance and cost.
• He said GPT-6.1 Sol will make it cheaper for AI agents to reuse earlier information, improve answers by trying different solutions, and complete longer tasks.
• According to Altman, Sol is “smarter than Astra in some ways”.
• He also said that GPT-6.1 Sol is expected to become a “daily workhorse”, meaning a model that people can use regularly for their everyday work.
• OpenAI’s developer documents state that GPT-6.1 Sol has been designed to offer a balance between capability and affordability.
• The model costs $2 for every one million input tokens.
• It costs $10 for every one million output tokens.
• GPT-6.1 Sol supports different levels of reasoning, from low to maximum.
• The model has a context window of 1.05 million tokens, allowing it to handle a very large amount of information at one time.
• It can generate responses containing up to 1,28,000 tokens.
• GPT-6.1 Sol supports several tools, including web search, file search, code interpretation, hosted shell, computer use, image generation, skills, and Model Context Protocol (MCP).
• Users can access the model through OpenAI’s Responses API.
• It also supports function calling and structured outputs.
• OpenAI also announced the launch of UltraFast across its API, ChatGPT, and Codex platforms.
• Sam Altman said UltraFast can operate at speeds of up to 300 tokens per second.
• He said UltraFast is eight times faster than the standard version.
• However, he added that it costs six times more than the standard offering.
• UltraFast is currently available with Astra.
• OpenAI said it will soon make UltraFast available with GPT-6.1 Sol as well.
• During the DevDay event, OpenAI also demonstrated Dots, which are always-active AI agents powered by GPT-6 Astra.
• The company said Dots have their own cloud-based computers.
• Dots can connect with more than 4,000 different applications.
• They can work on several projects at the same time without users having to guide every step.
• These AI agents can be used through ChatGPT, Slack, and Microsoft Teams.
• OpenAI has also started enterprise pilot programmes for specialised Dots.
• The company said these specialised Dots can have their own identities and credentials.
• They can also be given access to company systems.
• These agents are designed to carry out specific tasks and responsibilities assigned to them.
• OpenAI said it is working with Microsoft to connect these agents with the governance and security controls available in Agent 365.
• These announcements came just one day after OpenAI confirmed that it had cancelled plans for GPT-6.1 Astra.
• GPT-6.1 Astra had originally been scheduled for release in October.
• In his closing speech at DevDay, Sam Altman said he does not like describing AI as a new industrial revolution.
• He called that description “quite off-putting”.
• Altman said the best future for AI should not be one where people become “cogs in a giant machine”.
• He said there are some parts of life that “cannot and should not” be automated.
• According to Altman, if AI is developed in the right way, it could instead bring about “a new renaissance”.
• He said such a future could give people more control over their own lives.
• He also said AI could provide people with more tools to create new things, learn, discover, and expand human knowledge.

Important Questions

1. Why did the Supreme Court question the Central Government over high mark-ups on essential medicines and suggest extending the 16% retailer margin under the Drugs (Prices Control) Order (DPCO), 2013 to all essential medicines?
2. What observations did the Supreme Court make about the large difference between the Price to Retailer (PTR) and the Maximum Retail Price (MRP) of medicines while hearing petitions on drug pricing and affordability?
3. Who represented India at the Shanghai Cooperation Organisation (SCO) National Coordinators’ meeting held in Islamabad, Pakistan, in September 2026?
4. What theme has Pakistan announced for its Shanghai Cooperation Organisation (SCO) Chairship for 2026–2027 while preparing to host the SCO Summit in 2027?
5. What is GPT-6.1 Sol, the new AI model introduced by OpenAI CEO Sam Altman at the DevDay event in San Francisco, and how does it compare with GPT-6 Astra?
6. What are Dots AI agents announced by OpenAI at DevDay, and what tasks and capabilities can they perform through ChatGPT, Slack, and Microsoft Teams?

Important Vocabulary

1. Carnage – Great destruction or severe damage.
2. Intervene – To become involved in a situation to change it.
3. Disproportionate – Too large or too small compared to something else.
4. Violations – Acts of breaking a law, rule, or agreement.
5. Preparatory – Done to prepare for a future event.
6. Allegations – Claims that someone has done something wrong.
7. Multilateral – Involving several countries or parties.
8. Observer – A participant who watches proceedings without full membership rights.
9. Affordability – The quality of being reasonably priced.
10. Interpretation – The act of explaining or understanding something.
11. Governance – The system of rules and control used to manage something.
12. Renaissance – A period of renewed growth, learning, or development.